%D8%AF%D8%A7%D8%A1_%D8%BA%D9%88%D8%B4%D9%8A%D9%87Malaltia_de_GaucherMorbus_GaucherGaucher%27s_diseaseEnfermedad_de_Gaucher%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C_%DA%AF%D9%88%D8%B4%D9%87Maladie_de_GaucherEnfermidade_de_Gaucher%D7%9E%D7%97%D7%9C%D7%AA_%D7%92%D7%95%D7%A9%D7%94Penyakit_GaucherMalattia_di_Gaucher%E3%82%B4%E3%83%BC%E3%82%B7%E3%82%A7%E7%97%85%EA%B3%A0%EC%85%94%EB%B3%91%D0%93%D0%BE%D1%88%D0%B5Penyakit_GaucherZiekte_van_GaucherChoroba_GaucheraDoen%C3%A7a_de_GaucherBoala_Gaucher%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%93%D0%BE%D1%88%D0%B5Gauchers_sjukdom%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B9%80%E0%B8%81%E0%B8%B2%E0%B9%80%E0%B8%8A%E0%B8%AD%E0%B8%A3%E0%B9%8CQ861645%E9%AB%98%E9%9B%AA%E6%B0%8F%E7%97%87
about
P2293
Imiglucerase in the treatment of Gaucher disease: a history and perspectiveEnzyme replacement in Gaucher diseaseRethinking fatigue in Gaucher diseaseEliglustat tartrate for the treatment of adults with type 1 Gaucher diseaseGaucher disease. Unusual presentation and mini-reviewMitochondrial dysfunction associated with glucocerebrosidase deficiencyA Review of Gaucher Disease Pathophysiology, Clinical Presentation and TreatmentsGaucher's disease: report of 11 cases with review of literature.Gaucher-Associated Parkinsonism.Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.Sphingolipids: the nexus between Gaucher disease and insulin resistance.Animal models for Gaucher disease research.Pathological looping in the synucleinopathies: investigating the link between Parkinson's disease and Gaucher disease.Gaucher disease and the synucleinopathies: refining the relationship.Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System.Induced Pluripotent Stem Cell Modeling of Gaucher's Disease: What Have We Learned?Death by over-eating: The Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for developmental cell death in Drosophila midgut.Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease.A health state utility valuation study to assess the impact of treatment mode of administration in Gaucher diseaseER retention and degradation as the molecular basis underlying Gaucher disease heterogeneityIntravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's DiseaseValidating a New Severity Score System for Adults With Type 1 Gaucher Disease (GD1)Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human GlucocerebrosidasePlant Cell Expressed Recombinant Human Glucocerebrosidase Extension TrialDetecting Dopaminergic Deficits in Individuals At-risk for ParkinsonismPharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher DiseaseReduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCTIntra-monocyte Imiglucerase Kinetics in Gaucher DiseaseA Multicenter Extension Study of Taliglucerase Alfa in Pediatric Subjects With Gaucher DiseaseA Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Subjects With Gaucher DiseaseExpanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher DiseaseTreatment Protocol of Velaglucerase Alfa for Patients With Type 1 Gaucher DiseaseMiglustat on Gaucher Disease Type IIIBAssessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using FibroscanSafety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease PatientsIdentification of Undiagnosed Gaucher DiseaseThrombocytopathy in Gaucher Disease PatientsStudy of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher DiseaseStudy of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With ImigluceraseA Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease
P921
description
Krankheit
@de
human disease characterized by ...... erebroside throughout the body
@en
malattia umana
@it
наследственное заболевание, самая распространённая из лизосомных болезней накопления
@ru
name
Boala Gaucher
@ro
Choroba Gauchera
@pl
Enfermidade de Gaucher
@gl
Gaucher's disease
@en
Gauchers sjukdom
@nn
Gauchers sjukdom
@sv
Malaltia de Gaucher
@ca
Mb. Gaucher
@bs
Morbus Gaucher
@de
Penyakit Gaucher
@id
type
label
Boala Gaucher
@ro
Choroba Gauchera
@pl
Enfermidade de Gaucher
@gl
Gaucher's disease
@en
Gauchers sjukdom
@nn
Gauchers sjukdom
@sv
Malaltia de Gaucher
@ca
Mb. Gaucher
@bs
Morbus Gaucher
@de
Penyakit Gaucher
@id
altLabel
Boală Gaucher
@ro
Doenza de Gaucher
@gl
Gaucher disease
@en
Gaucher's disease
@ja
Gaucher's disease
@th
Gaucher-Krankheit
@de
Gaucher-Syndrom
@de
Gaucher病
@ja
Glucocerebrosidase deficiency
@en
Norrbottensjukan
@sv
prefLabel
Boala Gaucher
@ro
Choroba Gauchera
@pl
Enfermidade de Gaucher
@gl
Gaucher's disease
@en
Gauchers sjukdom
@nn
Gauchers sjukdom
@sv
Malaltia de Gaucher
@ca
Mb. Gaucher
@bs
Morbus Gaucher
@de
Penyakit Gaucher
@id
P2176
P2293
P2888
P492
P672
P244
P349
P486
P646
P672
P1193
0.00001225
P138
P1417
science/Gaucher-disease
P1461
gauchers-disease-pro